Schizophrenia Research
Volume 116, Issue 1 , Pages 61-67 , January 2010

The dopamine D3 receptor (DRD3) gene and risk of schizophrenia: Case–control studies and an updated meta-analysis

  • Ayako Nunokawa

      Affiliations

    • Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, 757 Asahimachidori-ichibancho, Chuo-ku, Niigata 951-8510, Japan
    • ,
  • Yuichiro Watanabe

      Affiliations

    • Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, 757 Asahimachidori-ichibancho, Chuo-ku, Niigata 951-8510, Japan
    • Health Administration Center, Niigata University, 8050 Ikarashi-ninocho, Nishi-ku, Niigata 950-2181, Japan
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, 757 Asahimachidori-ichibancho, Chuo-ku, Niigata 951-8510, Japan. Tel.: +81 25 227 2213; fax: +81 25 227 0777.
    • ,
  • Naoshi Kaneko

      Affiliations

    • Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, 757 Asahimachidori-ichibancho, Chuo-ku, Niigata 951-8510, Japan
    • ,
  • Takuro Sugai

      Affiliations

    • Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, 757 Asahimachidori-ichibancho, Chuo-ku, Niigata 951-8510, Japan
    • ,
  • Saori Yazaki

      Affiliations

    • Department of Medical Genetics, Doctoral Program in Social and Environmental Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan
    • ,
  • Tadao Arinami

      Affiliations

    • Department of Medical Genetics, Doctoral Program in Social and Environmental Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan
    • ,
  • Hiroshi Ujike

      Affiliations

    • Department of Neuropsychiatry, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan
    • ,
  • Toshiya Inada

      Affiliations

    • Seiwa Hospital, Institute of Neuropsychiatry, 91 Bentencho, Shinjuku-ku, Tokyo 162-0851, Japan
    • ,
  • Nakao Iwata

      Affiliations

    • Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan
    • ,
  • Hiroshi Kunugi

      Affiliations

    • Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan
    • ,
  • Tsukasa Sasaki

      Affiliations

    • Health Service Center, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
    • ,
  • Masanari Itokawa

      Affiliations

    • Schizophrenia Research Project, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan
    • ,
  • Norio Ozaki

      Affiliations

    • Department of Psychiatry, School of Medicine, Nagoya University, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan
    • ,
  • Ryota Hashimoto

      Affiliations

    • The Osaka-Hamamatsu Joint Research Center for Child Mental Development, Osaka University Graduate School of Medicine, D3, 2-2, Yamadaoka, Suita, Osaka, 5650871, Japan
    • ,
  • Toshiyuki Someya

      Affiliations

    • Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, 757 Asahimachidori-ichibancho, Chuo-ku, Niigata 951-8510, Japan

Received 13 July 2009 ,Revised 15 October 2009 ,Accepted 17 October 2009.

References 

  1. Allen NC, Bagade S, McQueen MB, Ioannidis JPA, Kavvoura FK, Khoury MJ, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 2008;40(7):827–834
  2. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–265
  3. Bombin I, Arango C, Mayoral M, Castro-Fornieles J, Gonzalez-Pinto A, Gonzalez-Gomez C, et al. DRD3, but not COMT or DRD2, genotype affects executive functions in healthy and first-episode psychosis adolescents. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008;147B(6):873–879
  4. Brzustowicz LM, Hodgkinson KA, Chow EWC, Honer WG, Bassett AS. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21–q22. Science. 2000;288(5466):678–682
  5. Costas J, Carrera N, Domínguez E, Vilella E, Martorell L, Valero J, et al. A common haplotype of DRD3 affected by recent positive selection is associated with protection from schizophrenia. Hum. Genet. 2009;124(6):607–613
  6. Crocq MA, Mant R, Asherson P, Williams J, Hode Y, Mayerova A, et al. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J. Med. Genet. 1992;29(12):858–860
  7. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat. Genet. 2005;37(11):1217–1223
  8. Domínguez E, Loza MI, Padín F, Gesteira A, Paz E, Páramo M, et al. Extensive linkage disequilibrium mapping at HTR2A and DRD3 for schizophrenia susceptibility genes in the Galician population. Schizophr. Res. 2007;90(1–3):123–129
  9. Egger M, Smith DG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634
  10. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science. 2002;296(5576):2225–2229
  11. Gurevich EV, Bordelon Y, Shapiro RM, Arnold SE, Gur RE, Joyce JN. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study. Arch. Gen. Psychiatry. 1997;54(3):225–232
  12. Ilani T, Ben-Shachar D, Strous RD, Mazor M, Sheinkman A, Kotler M, et al. A peripheral marker for schizophrenia: increased levels of D3 dopamine receptor mRNA in blood lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 2001;98(2):625–628
  13. Ishiguro H, Okuyama Y, Toru M, Arinami T. Mutation and association analysis of the 5′ region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia. Mol. Psychiatry. 2000;5(4):433–438
  14. Kaneko N, Muratake T, Kuwabara H, Kurosaki T, Takei M, Ohtsuki T, et al. Autosomal linkage analysis of a Japanese single multiplex schizophrenia pedigree reveals two candidate loci on chromosomes 4q and 3q. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007;144B(6):735–742
  15. Kennedy JL, Billett EA, Macciardi FM, Verga M, Parsons TJ, Meltzer HY, et al. Association study of dopamine D3 receptor gene and schizophrenia. Am. J. Med. Genet. 1995;60(6):558–562
  16. Li Y, Abecasis GR. Mach 1.0: rapid haplotype reconstruction and missing genotype inference. Am. J. Hum. Genet. 2006;S79:2290
  17. Lundstrom K, Turpin MP. Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system. Biochem. Biophys. Res. Commun. 1996;225(3):1068–1072
  18. Ma G, He Z, Fang W, Tang W, Huang K, Li Z, et al. The Ser9Gly polymorphism of the dopamine D3 receptor gene and risk of schizophrenia: an association study and a large meta-analysis. Schizophr. Res. 2008;101(1–3):26–35
  19. Meador-Woodruff JH, Haroutunian V, Powchik P, Davidson M, Davis KL, Watson SJ. Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia. Arch. Gen. Psychiatry. 1997;54(12):1089–1095
  20. Mulert C, Juckel G, Giegling I, Pogarell O, Leicht G, Karch S, et al. A Ser9Gly polymorphism in the dopamine D3 receptor gene (DRD3) and event-related P300 potentials. Neuropsychopharmacology. 2006;31(6):1335–1344
  21. Nunokawa A, Watanabe Y, Muratake T, Kaneko N, Koizumi M, Someya T. No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population. Neurosci. Res. 2007;58(3):291–296
  22. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2003;19(1):149–150
  23. Roussos P, Giakoumaki SG, Bitsios P. The dopamine D3 receptor Ser9Gly polymorphism modulates prepulse inhibition of the acoustic startle reflex. Biol. Psychiatry. 2008;64(3):235–240
  24. Rybakowski JK, Borkowska A, Czerski PM, Hauser J. Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects. Mol. Psychiatry. 2001;6(6):718–724
  25. Rybakowski JK, Borkowska A, Czerski PM, Kapelski P, Dmitrzak-Weglarz M, Hauser J. An association study of dopamine receptors polymorphisms and the Wisconsin Card Sorting Test in schizophrenia. J. Neural Transm. 2005;112(11):1575–1582
  26. Schmauss C, Haroutunian V, Davis KL, Davidson M. Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. Proc. Natl. Acad. Sci .U. S. A. 1993;90(19):8942–8946
  27. Schwartz JC, Diaz J, Pilon C, Sokoloff P. Possible implications of the dopamine D3 receptor in schizophrenia and in antipsychotic drug actions. Brain Res. Brain Res. Rev. 2000;31(2–3):277–287
  28. Shaikh S, Collier DA, Sham PC, Ball D, Aitchison K, Vallada H, et al. Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. Hum. Genet. 1996;97(6):714–719
  29. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 1990;347(6289):146–151
  30. Szekeres G, Kéri S, Juhász A, Rimanóczy Á, Szendi I, Czimmer C, et al. Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004;124B(1):1–5
  31. Talkowski ME, Mansour H, Chowdari KV, Wood J, Butler A, Varma PG, et al. Novel, replicated associations between dopamine D3 receptor gene polymorphisms and schizophrenia in two independent samples. Biol. Psychiatry. 2006;60(6):570–577
  32. Tanaka T, Igarashi S, Onodera O, Tanaka H, Takahashi M, Maeda M, et al. Association study between schizophrenia and dopamine D3 receptor gene polymorphism. Am. J. Med. Genet. 1996;67(4):366–368
  33. Tsai SJ, Yu YW, Chen TJ, Chen MC, Hong CJ. Association analysis for dopamine D3 receptor, dopamine D4 receptor and dopamine transporter genetic polymorphisms and P300 event-related potentials for normal young females. Psychiatr. Genet. 2003;13(1):51–53
  34. Utsunomiya K, Shinkai T, De Luca V, Hwang R, Sakata S, Fukunaka Y, et al. Genetic association between the dopamine D3 gene polymorphism (Ser9Gly) and schizophrenia in Japanese populations: evidence from a case–control study and meta-analysis. Neurosci. Lett. 2008;444(2):161–165
  35. Vogel M, Pfeifer S, Schaub RT, Grabe HJ, Barnow S, Freyberger HJ, et al. Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients. Neuropsychobiology. 2004;50(4):305–310
  36. Watanabe Y, Muratake T, Kaneko N, Nunokawa A, Someya T. No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population. Schizophr. Res. 2006;84(1):29–35
  37. Watanabe Y, Nunokawa A, Kaneko N, Someya T. Meta-analysis of case–control association studies between the C270T polymorphism of the brain-derived neurotrophic factor gene and schizophrenia. Schizophr. Res. 2007;95(1–3):250–252

PII: S0920-9964(09)00503-9

doi: 10.1016/j.schres.2009.10.016

Schizophrenia Research
Volume 116, Issue 1 , Pages 61-67 , January 2010

Article Tools

* Image Usage & Resolution